Support PenkeLifeMD Inc - Trending symbols
Latest News of LifeMD Inc
| Date | Title | Read |
|---|---|---|
| 2025-05-06 22:05 | LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance | Read |
| 2025-04-30 11:30 | Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead | Read |
| 2025-04-29 14:05 | LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients | Read |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | -231 | -3,841 | -4,072 | 55 | -4,017 | 1,888 | -2,129 | 5,695 | 3,565 | |
| Income before Tax | -2,794 | -3,855 | -6,649 | -188 | -6,837 | 1,592 | -5,245 | 5,649 | 404 | |
| Net Income from Continuing Operations | -3,222 | -3,427 | -6,649 | -188 | -6,837 | 1,360 | -5,477 | 5,712 | 235 | |
| EBIT | -2,172 | -4,000 | -6,171 | -134 | -6,306 | 1,619 | -4,686 | 5,704 | 1,018 | |
| Minority Interest | -839 | 329 | -510 | 390 | -119 | 81 | -39 | 384 | 346 | |
| Operating Income | -4,569 | 2,398 | -2,172 | -4,000 | -6,171 | -134 | -6,306 | 9,148 | 2,842 | |
| Cost of Revenue | 4,782 | 2,633 | 7,414 | -966 | 6,448 | 1,310 | 7,758 | -15,862 | -8,104 | |
| Long-term Assets Other | -14,705 | -560 | -15,265 | -539 | -15,805 | 15,805 | 0 | 12,023 | 12,023 | |
| Total Stockholder Equity | -6,830 | -500 | -7,330 | -3,659 | -10,989 | -1,683 | -12,671 | 16,177 | 3,505 | |
| Net Debt | 169 | 4,782 | 4,951 | -1,548 | 3,403 | 1,458 | 4,861 | -19,075 | -14,214 | |
| Net Working Capital | -20,063 | 12,209 | -7,854 | -3,483 | -11,337 | 3,701 | -7,636 | 15,458 | 7,823 | |
| Minority Interest | -1,033 | 233 | -800 | 324 | -476 | 444 | -31 | 815 | 784 | |
| Income Tax Expense | 115 | 1,126 | 1,241 | -880 | 361 | 6,280 | 6,640 | -12,024 | -5,383 | |
| Total Other Income Expense Net | -902 | -923 | -1,825 | -2,509 | -4,334 | 4,166 | -168 | 2,834 | 2,666 | |
| Net Tangible Assets | -3,018 | 2,288 | -730 | -7,566 | -8,296 | -11,213 | -19,509 | 39,233 | 19,724 | |
| Interest Expense | 355 | -215 | 139 | 762 | 902 | 923 | 1,825 | -4,844 | -3,020 |
Comments
How you think about this?